MedTrace Logo

SMART Trial: Intrapersonal and Interpersonal Stigma Reduction

NCT04693416 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2023-03-09

Study results available
· View outcomes & findings →

Summary

The goal of this project is to develop a multicomponent stigma reduction intervention to address intrapersonal (individual) stigma regarding Opioid Use Disorder (OUD). The intervention will address this cost/benefit evaluation among individuals known to face intersecting stigma of OUD and African American race, with treatment elements chosen explicitly to increase the value of treatment using salient forms of reward, and to ease perceived costs through explicit services in an effort to encourage the occurrence of the first treatment visit for OUD.

Conditions

Interventions

OTHER

Intrapersonal Stigma Reduction

Brief intervention for stigma reduction

OTHER

Interpersonal Stigma Reduction

Brief intervention for support persons of intrapersonal intervention participants.

Sponsors & Collaborators

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • University of Tennessee

    lead OTHER

Principal Investigators

  • Karen J Derefinko, PhD · University of Tennessee

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-08
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04693416 on ClinicalTrials.gov